European Investment in Sexual & Reproductive Health R&D: Steady Overall but Room to Grow

By Policy Cures Research (now Impact Global Health) 15 February 2024

20 min read
Sexual & Reproductive HealthPre-eclampsia and eclampsiaPost-partum haemorrhage (PPH)Multipurpose prevention technologies (MPTs)

G-FINDER snapshot

This snapshot offers an up-to-date insight into European support for sexual & reproductive health (SRH) issues biomedical research & development (R&D) across the five years covering 2018 to 2022.

Data has largely been drawn from two key projects through Policy Cures Research which track the R&D landscape for SRH: the G-FINDER project, which tracks and reports annually on the landscape of investment into low- and middle-income country (LMIC) appropriate R&D for new products and technologies to address a range of global health challenges, including SRH; and the Accelerating Innovations for Mothers project, which collects comprehensive data on the R&D pipeline for a number of critical maternal health conditions where biomedical product gaps exist.

Data for this report was also drawn from the Calliope Contraceptive Pipeline Database and the iMPT Product Development Database, which collect data on the R&D pipeline for contraception and multipurpose prevention technologies (MPTs), respectively.

Table of contents

  1. G-FINDER snapshot